LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.73 | 770.25 | 1354 | 1664 | 0.8135 | 0.6610 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.95 | 770.25 | 1332 | 1832 | 0.7269 | 0.5497 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.95 | 770.25 | 1327 | 1832 | 0.7242 | 0.5450 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.95 | 770.25 | 1412 | 1832 | 0.7705 | 0.6237 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.17 | 770.25 | 1382 | 2008 | 0.6881 | 0.5262 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.17 | 770.25 | 1389 | 2008 | 0.6916 | 0.5318 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.17 | 770.25 | 1436 | 2008 | 0.7150 | 0.5691 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.39 | 770.25 | 1451 | 2244 | 0.6465 | 0.5075 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.39 | 770.25 | 1456 | 2244 | 0.6487 | 0.5108 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.39 | 770.25 | 1521 | 2244 | 0.6777 | 0.5542 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.62 | 770.25 | 1557 | 2514 | 0.6191 | 0.5103 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.62 | 770.25 | 1573 | 2514 | 0.6255 | 0.5193 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.62 | 770.25 | 1578 | 2514 | 0.6275 | 0.5222 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.84 | 770.25 | 1680 | 2833 | 0.5928 | 0.5143 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.84 | 770.25 | 1715 | 2833 | 0.6052 | 0.5310 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.84 | 770.25 | 1660 | 2833 | 0.5858 | 0.5047 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 30.06 | 770.25 | 1782 | 3106 | 0.5737 | 0.5173 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 30.06 | 770.25 | 1824 | 3106 | 0.5872 | 0.5350 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 30.06 | 770.25 | 1792 | 3106 | 0.5769 | 0.5216 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 32.28 | 770.25 | 1888 | 3392 | 0.5565 | 0.5206 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 32.28 | 770.25 | 1953 | 3392 | 0.5756 | 0.5449 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 32.28 | 770.25 | 1886 | 3392 | 0.5559 | 0.5199 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 34.50 | 770.25 | 2033 | 3712 | 0.5477 | 0.5339 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 34.50 | 770.25 | 2092 | 3712 | 0.5636 | 0.5533 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 34.50 | 770.25 | 1979 | 3712 | 0.5331 | 0.5158 | MN20160304_L02 | K06 |